Distribution of CT antigen IHC scoring in patients with stage-III multiple myeloma
mAb/antigen . | Negative, - (%) . | Pos (%) . | Focal, less than 5% (%) . | +, 5%-25% (%) . | ++, 25%-50% (%) . | +++, 50%-75% (%) . | ++++, greater than 75% (%) . |
|---|---|---|---|---|---|---|---|
| CT7-33/CT7 | 6/33 (18) | 27/33 (82) | 4/33 (12) | 4/33 (12) | 7/33 (21) | 5/33 (15) | 7/33 (21) |
| M3H67/MAGE-A3/6 | 10/33 (30) | 23/33 (70) | 5/33 (15) | 3/33 (9) | 9/33 (27) | 3/33 (9) | 3/33 (9) |
| E978/NY-ESO-1 | 26/33 (79) | 7/33 (21) | 4/33 (12) | 3/33 (9) | 0/33 (0) | 0/33 (0) | 0/33 (0) |
mAb/antigen . | Negative, - (%) . | Pos (%) . | Focal, less than 5% (%) . | +, 5%-25% (%) . | ++, 25%-50% (%) . | +++, 50%-75% (%) . | ++++, greater than 75% (%) . |
|---|---|---|---|---|---|---|---|
| CT7-33/CT7 | 6/33 (18) | 27/33 (82) | 4/33 (12) | 4/33 (12) | 7/33 (21) | 5/33 (15) | 7/33 (21) |
| M3H67/MAGE-A3/6 | 10/33 (30) | 23/33 (70) | 5/33 (15) | 3/33 (9) | 9/33 (27) | 3/33 (9) | 3/33 (9) |
| E978/NY-ESO-1 | 26/33 (79) | 7/33 (21) | 4/33 (12) | 3/33 (9) | 0/33 (0) | 0/33 (0) | 0/33 (0) |
Results are shown for a total of 33 patients.